Stock A092730 NEOPHARM CO., LTD.
Add to a list
To use this feature you must be a member
Log inSign up

Total Return chart NeoPharm CO., LTD.

Equities

A092730

KR7092730001

End-of-day quote Korea S.E.
Other stock markets
 23:00:00 30/05/2024 BST 		5-day change 1st Jan Change
28,000 KRW -0.18% Intraday chart for NeoPharm CO., LTD. -.--% +8.32%
2023 NeoPharm CO., LTD. Reports Earnings Results for the First Quarter Ended March 31, 2023 CI
2019 NeoPharm CO., LTD. announced that it has received KRW 31.970667276 billion in funding CI
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.

Past dividends on NeoPharm CO., LTD.

26/12/2023 Annual 750 KRW
27/12/2022 Annual 700 KRW
28/12/2021 Annual 700 KRW
28/12/2020 Annual 650 KRW
26/12/2019 Annual 750 KRW
26/12/2018 Annual 650 KRW
26/12/2017 Annual 500 KRW
27/12/2016 Annual 350 KRW
28/12/2015 Annual 250 KRW
28/12/2014 Annual 250 KRW
26/12/2013 Annual 100 KRW
26/12/2012 Annual 75 KRW
27/12/2011 Annual 75 KRW
28/12/2010 Annual 50 KRW
28/12/2009 Annual 80 KRW
28/12/2008 Annual 125 KRW
26/12/2007 Annual 50 KRW
27/06/2007 Annual 150 KRW
  1. Stock Market
  2. Equities
  3. A092730 Stock
  4. Charts NeoPharm CO., LTD.
  5. Total Return chart